Skip to main content

Table 1 Participant demographics and baseline data from participants who completed the 12 month assessment

From: Cost-effectiveness of using a motion-sensor biofeedback treatment approach for the management of sub-acute or chronic low back pain: economic evaluation alongside a randomised trial

 

Intervention

Control

n

38

45

Age

39 (14)

49 (12)

Gender

18 (47%) female

26 (58%) female

Pain intensity (QVAS) (0–100 scale, mean)

61.4 (16.0)

61.0 (12.0)

Pain episode duration (weeks, median)

52 (IQR: 17.5, 62.5)

52 (IQR: 16, 364)

Fear of movement (Fear Avoidance Beliefs Questionnaire: Physical Activity subscale) (0–24 scale, mean)

14.4 (6.4)

14.2 (6.6)

Activity limitation (Patient Specific Functional Scale) (0–100 scale, mean)

3.9 (1.7)

4.4 (2.4)

Activity limitation (Roland-Morris Disability Questionnaire) (0–100 scale, mean)

52.6 (19.9)

45.6 (26.4)

$AUD medication use per day at baseline

$1.03 ($0.91)

$0.96 ($0.75)

$AUD weekly income estimate based on gender and industry codes

$1467 ($265)

$1433 ($301)

Employment industry codes

 Professional, Scientific and Technical services

10 (26%)

5 (11%)

 Health Care and Social Assistance

4 (11%)

10 (22%)

 Agricultural, Forestry and Fishing

4 (11%)

5 (11%)

 Administrative and Support services

4 (11%)

3 (7%)

 Education and Training

2 (5%)

5 (11%)

 Transport, Postal and Warehousing

2 (5%)

3 (7%)

 Other categories

12 (32%)

14 (31%)

  1. Data are mean (sd) or n (%) unless otherwise indicated